Herein, HSA was used as the carrier to prepare MnO2, which can be further linked with tumor antigenic peptides to prepare STING-activating peptide nanovaccine (HSA-MnO2-pep) for tumor prevention and therapy. This evidence concerns the gene STING1 and neoplasm.